• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …

Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …

The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral
Arterial Disease (TASC) was published in January 2000 1-3 as a result of cooperation …

Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …

Lower extremity peripheral arterial disease (PAD) most frequently presents with pain during
ambulation, which is known as" intermittent claudication". Some relief of symptoms is …

These guidelines address the diagnosis and management of atherosclerotic, aneurysmal,
and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD …

OBJECTIVES: Current multidisciplinary guidelines recommend to treat extensive aortoiliac
occlusive disease (AIOD) by surgical revascularization. Surgery provides good long-term …

OBJECTIVE: This trial was conducted to determine if covered stents offer a patency
advantage over bare-metal stents in the treatment of aortoiliac arterial occlusive disease …

Purpose To examine clinical outcomes of endovascular and open bypass treatment for
aortoiliac occlusive disease (AIOD). Methods Multiple databases were systematically …